Goto, Hideki
Izutsu, Koji
Ennishi, Daisuke
Mishima, Yuko
Makita, Shinichi
Kato, Koji
Hanaya, Miyoko
Hirano, Satoshi
Narushima, Kazuya
Teshima, Takanori http://orcid.org/0000-0002-0941-271X
Nagai, Hirokazu
Ishizawa, Kenichi
Funding for this research was provided by:
Kyowa Kirin Co., Ltd.
Article History
Received: 29 March 2022
Revised: 28 August 2022
Accepted: 29 August 2022
First Online: 15 September 2022
Declarations
:
: Hideki Goto received personal fees from Celgene/BMS, Eisai, Janssen, Chugai, Novartis, SymBio, and Daiichi-Sankyo. Koji Izutsu received research grants from Novartis, Eisai, Kyowa Kirin, MSD, Takeda, Janssen, Mundipharma, Chugai, AbbVie, Bayer, Ono, Gilead, Zenyaku, Celgene, Solasia, Symbio, Astellas, Astellas Amgen, and Daiichi-Sankyo, and personal fees from Kyowa Kirin, MSD, Takeda, Janssen, Bristol-Myers Squibb, Dainippon Sumitomo, Mundipharma, Nihon Mediphysics, Chugai, Astra Zeneca, AbbVie, Bayer, Ono, and Celgene. Daisuke Ennishi declares no competing interests. Yuko Mishima received research fees from Kyowa Kirin, Taiho, Eisai, and Bristol-Myers Squibb, and personal fee from Chugai. Shinichi Makita received personal fees from Celgene/BMS, CSL Behring, Eisai, Chugai, Novartis, SymBio, and Takeda, and consulted for Celgene/BMS, Daiichi-Sankyo, and Takeda. Koji Kato received research grants from Chugai, Takeda, Kyowa Kirin, AbbVie, Novartis, Eisai, Janssen, Celgene/BMS, Ono, and Daiichi-Sankyo, and personal fees from Kyowa Kirin, Novartis, Takeda, and Chugai. Miyoko Hanaya is an employee of Kyowa Kirin Co., Ltd. Satoshi Hirano is an employee of Kyowa Kirin Co., Ltd. Kazuya Narushima is an employee of Kyowa Kirin Co., Ltd. Takanori Teshima received research grants and personal fees from Novartis. Hirokazu Nagai received grants from AbbVie, Solasia, HUYA, Otsuka, and IQVIA, and grants and personal fees from Janssen, Celgene, Mundi, Bayer, Takeda, Kyowa Kirin, Eisai, Bristol-Myers Squibb, Ono, Gilead, Zenyaku, AstraZeneca, and SymBio, and personal fees from Roche and Sanofi. Kenichi Ishizawa received grants from Pfizer, Kyowa Kirin, Sanofi, AbbVie, Otsuka, and Takeda, and personal fees from Chugai, Kyowa Kirin, MSD, Janssen, Celgene, Eisai, Ono, Novartis, and Takeda.